Hemispherx Biopharma Formally Collaborates With the Swiss Department of Defense, Civil Protection and Sports to Study Alferon(R) Against Tamiflu Resistant Influenza Virus Strains
May 14, 2014 08:30 ET
|
AIM ImmunoTech Inc.
PHILADELPHIA, May 14, 2014 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the "Company" or "Hemispherx"), announced that it has entered into a formal collaborative research agreement...
Battelle Introduces Next Generation, Smart Technology for Biodefense and Hazard Avoidance
April 28, 2014 08:05 ET
|
Battelle
COLUMBUS, OH--(Marketwired - Apr 28, 2014) - Battelle, the world's largest independent research and development organization, today announced production of the next generation chemical and...
PositiveID Corporation Appoints Lyle L. Probst President
April 21, 2014 08:30 ET
|
PositiveID Corporation
DELRAY BEACH, Fla., April 21, 2014 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or "Company") (OTCQB:PSID), a developer of biological detection and diagnostics solutions, announced today...
Investorideas.com Security Conference Adds Viscount Systems (OTCQB: VSYS) to Presenters; Speakers Discuss Key Security Issues Including Biodefense, Biometrics and Cybersecurity
February 20, 2014 14:05 ET
|
InvestorIdeas.com
NEW YORK, NY--(Marketwired - Feb 20, 2014) - Investorideas.com, an investor research and news portal covering leading sectors including technology and defense, announces new speakers and presenters...
Aeolus Announces First Quarter Fiscal Year 2014 Financial Results
February 14, 2014 17:30 ET
|
Aeolus Pharmaceuticals
MISSION VIEJO, CA--(Marketwired - Feb 14, 2014) - Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS), a biotechnology company developing compounds to protect against radiological and chemical threats with...
Aeolus Announces Process Improvements and Positive 18 Month Stability Results for AEOL 10150 in New Formulation
February 13, 2014 07:30 ET
|
Aeolus Pharmaceuticals
MISSION VIEJO, CA--(Marketwired - Feb 13, 2014) - Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS)
90% reduction in manufacturing cost of drug substance achieved;...
Investorideas.com Security and Defense Conference Adds Biodefense Company PositiveID (OTCQB: PSID) to Presenters: Themes Include Biodefense, Biometrics and Cybersecurity
February 11, 2014 14:59 ET
|
InvestorIdeas.com
NEW YORK, NY--(Marketwired - Feb 11, 2014) - Investorideas.com, an investor research and news portal covering leading sectors including technology and defense, announces new speakers for its...
Aeolus Announces Publication of Data Demonstrating Efficacy of AEOL 10150 in Animal Model of Lung Radiation Exposure; Models Developed for Pivotal Efficacy Studies
February 10, 2014 07:30 ET
|
Aeolus Pharmaceuticals
MISSION VIEJO, CA--(Marketwired - Feb 10, 2014) - Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS)
Three papers published in Health Physics, Volume 106, Number 1 (January 2014)
...
Investorideas.com Security and Defense Conference Adds Kris Tuttle Director of Research for SoundView Technology Group, Cybersecurity and Counterterrorism Analyst Roger Cressey, Homeland Security and Cybersecurity Expert Kiersten Todt, Both of Liberty Group Ventures
January 24, 2014 10:35 ET
|
InvestorIdeas.com
NEW YORK, NY--(Marketwired - Jan 24, 2014) - Investorideas.com, an investor research and news portal covering leading sectors including technology and defense, announces new speakers for its...
Aeolus Receives Orphan Drug Designation for AEOL 10150 From U.S. FDA
January 23, 2014 10:52 ET
|
Aeolus Pharmaceuticals
MISSION VIEJO, CA--(Marketwired - Jan 23, 2014) - Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS), a biotechnology company developing compounds to protect against radiological and chemical threats with...